TDC
NVS icon

Thompson Davis & Co’s Novartis NVS Stock Holding History

Thompson Davis & Co’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-473
Closed -$36K – 943
2017
Q3 		$36K Buy
473
+209
+79% +$15.8K 0.06% 313
2017
Q2 		$20K Buy
264
+4
+2% +$283 0.03% 466
2017
Q1 		$17K Sell
260
-115
-31% -$7.66K 0.02% 549
2016
Q4 		$24K Hold
375
– – 0.04% 433
2016
Q3 		$27K Buy
375
+36
+11% +$2.62K 0.05% 386
2016
Q2 		$25K Sell
339
-27
-7% -$1.86K 0.04% 400
2016
Q1 		$24K Sell
366
-318
-46% -$21.6K 0.04% 398
2015
Q4 		$53K Hold
684
– – 0.07% 248
2015
Q3 		$56K Sell
684
-2
-0.3% -$178 0.08% 247
2015
Q2 		$60K Sell
686
-30
-4% -$2.75K 0.07% 275
2015
Q1 		$63K Sell
716
-1,061
-60% -$94.1K 0.08% 244
2014
Q4 		$148K Sell
1,777
-446
-20% -$37K 0.17% 121
2014
Q3 		$188K Buy
2,223
+688
+45% +$55.7K 0.24% 92
2014
Q2 		$124K Buy
1,535
+1,116
+266% +$87.8K 0.18% 137
2014
Q1 		$32K Sell
419
-697
-62% -$50.8K 0.05% 317
2013
Q4 		$80K Buy
+1,116
New +$77.6K 0.12% 187

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Thompson Davis & Co's NVS Position: Q4 2017 in Review

Thompson Davis & Co sold out of Novartis (NVS) in Q4 2017, closing a stake of 473 shares — an estimated $36K sold.

Thompson Davis & Co first reported a position in NVS in Q4 2013 and held it in 16 quarters. The position peaked at $188K in Q3 2014. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

  • Thompson Davis & Co reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 473 Novartis shares in Q4 2017, an estimated $36K.
  • Thompson Davis & Co first reported a position in Novartis in Q4 2013 and held it in 16 quarters.
  • Thompson Davis & Co's Novartis position peaked at $188K in Q3 2014.
  • 1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.